Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4, Open-label, Non-randomized, Prospective Study of OZURDEX® in the Treatment of Diabetic Macular Oedema - The AUSSIEDEX Study

NCT02731911 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02731911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02731911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4, Open-label, Non-randomized, Prospective Study of OZURDEX® in the Treatment of Diabetic Macular Oedema - The AUSSIEDEX Study
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
April 29, 2016
Completion date
October 22, 2018
Enrollment
202 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular oedema